By PTI NEW DELHI: The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin,...
Covishield
Express News Service BENGALURU: With Bharat Biotech, the maker of India’s indigenous vaccine Covaxin, announcing its interim Phase-3 trial data on Wednesday, experts and the...
Express News Service NEW DELHI: The first-ever data on the effectiveness of the Covishield vaccine in India has shown that it works faster in...
The vaccination drive in the country was expanded from Monday to include people above 60 years of age and those aged between 45 and...
MEA spokesperson Anurag Srivastava said the supply of vaccines to countries will continue in the coming weeks and months in a phased manner.
By PTI NEW DELHI: The credibility of the made-in-India vaccines is evident with those being sought by and sent to a number of countries,...
Express News Service BHOPAL: A 58-year-old woman clerk working in the health department died at a private hospital around 12 hours after getting a...
By ANI NEW DELHI: Pune-based Serum Institute of India CEO Adar Poonawalla requested the countries to ‘be patient’ as they await the Covishield supplies,...
NEW DELHI: As the COVID-19 vaccination numbers crossed the 8 million-mark, administration of the second dose of the vaccine to those who took the first...
By PTI NEW DELHI: The government has placed orders for 1 crore additional doses of Covishield from Serum Institute of India and 45 lakh...